| Date | Time | Source | Headline | Symbol | Company |
| 06/06/2011 | 20:57 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/05/2011 | 17:49 | Zacks | Risk-Reward Balanced at Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/05/2011 | 21:14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 13/05/2011 | 17:55 | Zacks | 1Q Loss Narrows at Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/05/2011 | 22:24 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/05/2011 | 21:11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/05/2011 | 21:05 | Business Wire | Allos Therapeutics and Mundipharma Announce Strategic Collaboration for FOLOTYN | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/05/2011 | 21:00 | Business Wire | Allos Therapeutics Reports First Quarter 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/05/2011 | 19:42 | Zacks | Mixed Results for CELG's Revlimid - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/05/2011 | 13:00 | Business Wire | Allos Therapeutics to Present at Upcoming Investor Conferences in May | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/05/2011 | 13:00 | Business Wire | Allos Therapeutics to Report First Quarter 2011 Results on May 10, 2011 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/05/2011 | 13:16 | Marketwired | Oncology Drug Makers Positioned for Long Term Growth | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 29/04/2011 | 21:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 29/04/2011 | 17:35 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 29/04/2011 | 17:31 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2011 | 18:01 | Zacks | Allos Therapeutics at Neutral - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/04/2011 | 16:20 | Zacks | Cancer Study to Continue at SPPI - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/03/2011 | 13:00 | Business Wire | Allos Therapeutics to Present at Upcoming Investor Conferences | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 18/03/2011 | 20:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/03/2011 | 11:35 | Marketwired | Speculative Biotech Firms Remain Popular Takeover Targets | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/03/2011 | 21:27 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 21:20 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 21:15 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 21:00 | Business Wire | Allos Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of FOLOTYN in Patients with Pre... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2011 | 21:00 | Business Wire | Allos Therapeutics Reports Fourth Quarter and Full Year 2010 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/03/2011 | 22:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/03/2011 | 22:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/03/2011 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/03/2011 | 22:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/03/2011 | 22:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |